NewzA family in Santiago, Dominican Republic, has spent one year and three months waiting for a high-cost medication essential for the remission of stage IV cancer diagnosed in the family patriarch. The situation highlights a prolonged administrative delay in acquiring critical treatment.
Frustrated by the ongoing inaction, the affected family has repeatedly encountered standard responses of being placed on waiting lists. The delay traces back to an initial waiting period dating from May 21, 2025, underscoring systemic challenges in accessing vital oncology drugs for advanced-stage patients.
In-depth summary · AI, neutral